Breaking News
47 minutes ago
Simantini Singh Deo
Ascentage Pharma names Dr. Faiçal Miyara as CBO and Jim Ziegler as CCO to drive its global business development and commercial expansion.
Simantini Singh Deo
Novartis wins FDA approval for Pluvicto in earlier-stage metastatic hormone-sensitive prostate cancer, nearly doubling eligible patients.
Simantini Singh Deo

XORTX Therapeutics appoints Depesh Narotam, a 20-year financial services veteran, as an independent director to its Board.
Simantini Singh Deo

Rose Hill Life Sciences names Jama Pitman, a 25-year biopharma veteran, as CEO to lead its psilocybin-based clinical programs.
Simantini Singh Deo
